Traded Sep 16 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director sold ~$653K of ROIV shares in the open market
Traded Aug 20, 2026 · Filed Aug 22, 2026
- ~$653K
- Approx. value · 18K sh @ $37.30
- 18.6M
- Holds after · shares reported
- −2.9%
- stock since the trade · S&P 500 +1.6%, $36.84 → $35.78 on Oct 5
Why it stands out
A Roivant Sciences director sold $653K of Roivant Sciences shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 20, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 22, 2026
Director$500K–$1M
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$653,459
Shares × reported transaction price
- Timing vs results
14 days after results of Aug 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Planned / mechanical clue